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Low socioeconomic status is associated
with worse lung function in the Danish
cystic fibrosis population
To the Editor:
Low socioeconomic status is associated with worse lung function and greater risk of death in people with
cystic fibrosis (CF) in the UK and USA, but there are no population level studies from other countries [1–4]. A
feature of previous analyses of inequalities in lung function in CF by socioeconomic status has been the
identification of a lung function deficit in more disadvantaged children, which is evident as soon as spirometry
can be routinely undertaken at ,5–6 years of age [1, 3]. The finding of a fixed lung function deficit in the
most deprived children in the early years of life has important policy implications, and suggests that
deprivation has a detrimental effect on lung health in the early years of a child’s life [5].
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We questioned whether similar patterns were evident in other CF populations, so assessed the effect of
socioeconomic status on lung function trajectory measured by forced expiratory volume in 1 s (FEV1) %
predicted in the Danish population. Therefore, we undertook a retrospective, longitudinal, cohort study of
all children and adults with CF who had contributed lung function measures to the Danish CF registry
between 1969 and 2010 who could be linked to the national level administrative registers.
Patients attending the two Danish CF centres (Copenhagen and Aarhus) were routinely seen every month in
the outpatient clinic for evaluation of clinical status, pulmonary function and microbiology of lower
respiratory tract secretions. It is estimated that coverage of CF patients resident in Denmark is almost
complete from 1990, when CF care was centralised. This coverage and the unparalleled frequency of
measurement make this a unique dataset for epidemiological research [6].
The primary outcome for the analysis was FEV1 % predicted. Pulmonary function tests were performed
according to international recommendations [7], measuring FEV1 expressed as % predicted for sex and
height using reference equations from WANG et al. [8] or HANKINSON et al. [9].
The primary exposure of interest was an individual measure of parental socioeconomic status. Data linkage
facilitated collection of data on highest parental education level at birth for each child born with CF,
measured using the International Standard Classification of Education (ISCED) score. Individuals were
coded as having low socioeconomic status if their highest educated parent had basic school level education
up to grade 10 (ISCED 1).
We first assessed the association between this binary socioeconomic status measure and the mean FEV1 %
predicted profile over time, fitted as a linear time trend with a change point, whilst adjusting for birth
cohort, sex and genotype (distribution of DF508 alleles) (baseline model). We then added clinical
characteristics in the final adjusted model (Pseudomonas aeruginosa status, pancreatic status and CF-related
diabetes). We used a mixed effects model with longitudinally structured correlation, previously developed
to analyse this dataset [6]. This approach provides a more realistic estimate of the FEV1 % predicted
trajectory of people with chronic lung disease by acknowledging the imprecision in individual
measurements and the correlation structure of repeated measurements on the same individual over time.
We estimated model parameters by maximum likelihood, using generalised likelihood ratio statistics to
compare nested models, and Wald statistics to test hypotheses about model parameters [10]. The study was
approved by the Danish Data inspectorate (Datatilsynet).
The linked dataset contains 65 729 lung function measures (22% low parental education versus 78% high
education) on 442 patients (21% low versus 79% high education) seen between 1969 and 2010 in Denmark.
The follow-up rates were similar in the two groups. In terms of the characteristics of the population
stratified by level of parental education, the distribution of DF508 alleles was similar in each group, as was
the median age at diagnosis. However, the low parental education group contained a greater proportion of
females (42% in the low parental education group versus 51% in the high parental education group), more
patients who died during follow-up (24% versus 17%), and more patients who developed chronic
P. aeruginosa infection (50% versus 42%) and CF-related diabetes (35% versus 23%).
There was no evidence to suggest a non-linear age effect in the longitudinal model; therefore, we modelled
the population average as a straight line. The difference in average annual rate of decline FEV1 (% per year)
was -0.32 (95% CI -0.57– -0.07)% predicted in the baseline model and -0.30 (95% CI -0.38– -0.22)%
predicted comparing low versus high educational status groups. In contrast, the onset of Pseudomonas
acquisition was associated with an independent effect size of -0.50 (95% CI -0.57– -0.42) percentage points
per year.
There was no statistically significant difference in the level of FEV1 % predicted at 6 years of age between
different socioeconomic status groups. Overall the low parental educational level was associated with a
change in FEV1 % predicted of -0.5 (95% CI -0.58– -0.39) percentage points per year after adjustment for
demographic, genetic and clinical factors (fig. 1).
This analysis confirms that people with CF from more disadvantaged backgrounds have worse lung
function, even in the context of a well-developed Danish health and welfare system. A key strength is the use
of a precisely recorded individual level measure of socioeconomic status, facilitated by data linkage systems
in Denmark, and the long period of follow-up.
This is the first population level study to clearly demonstrate a difference in the longitudinal rate of decline
of lung function in CF on the basis of socioeconomic status, but in contrast to previous studies there was no
evidence of a significant social difference at 6 years of age. In the UK people from the most deprived areas
have significantly worse lung function (FEV1 % predicted -4.12 (95% C1 -5.01– -3.19) percentage points) at
5 years of age, but the social gap in FEV1 % predicted did not increase over time. By contrast, in the analysis
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presented here, an equivalent gap of four percentage points between the most and least advantaged groups
(on the basis of parental education) develops in Denmark at ,17 years of age. In the cross-sectional study
of US data by SCHECHTER et al. [1], large inequalities in FEV1 % predicted by Medicaid status were evident at
5 years of age (9% difference), and these widened slightly up to 20 years of age. In their longitudinal US
study, O’CONNOR et al. [2] found a difference of 5.5% between the most and least deprived income
quintiles, which did not increase significantly over time.
There are several possible explanations for the differences between the studies. Methodological differences
between these studies mean that direct comparison between the UK, USA and Denmark on the magnitude
of the deprivation gap in lung function is inappropriate since the socioeconomic exposure measures used
are different. The UK and US studies used area-based measures of deprivation or income, whereas this study
used a precise individual level measure of maternal educational status. Furthermore, the high frequency
follow-up in this unique Danish dataset has allowed us to fit a more sophisticated model, which we believe
leads to more efficient estimation of the rate of lung function decline in Denmark [6].
However, the differences may reflect substantive societal level differences between Denmark, the UK and the
USA, or differences in CF care. For instance we can speculate that the Danish welfare system, coupled with
lower levels of child poverty, and universal access to high quality healthcare may reduce social differences in
outcomes in early childhood [11]. Furthermore, the approach to CF care in Denmark, characterised by
monthly follow-up and aggressive treatment of infections, may protect the most disadvantaged in the early
years. We can further speculate that the emergence of individual level factors, such as disease self-
management, may play more of a role in later life, and may account for the deterioration in lung function
seen in more disadvantaged children at older ages in Denmark.
Low socioeconomic status can damage lung function in the early years, and can also lead to an increased
rate of decline over the longer term. This suggests that environmental and social factors have an important
influence on lung function in people with CF, which act across the life course, starting from an early age [3, 12].
Tobacco smoke exposure may be an important mediator of the relationship between socioeconomic status and
adverse outcomes in CF, since there are striking and persistent differences in smoking prevalence by
socioeconomic status in the general population in Denmark [11] and the UK [5], and environmental tobacco
smoke exposure is associated with poorer growth and lung function in CF [13]. Policies should focus on
providing additional support to children and adults with CF from more disadvantaged backgrounds over the
life course, with a focus on getting things right in the early years [14].
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FIGURE 1 The effect of socioeconomic status as measured by parental education level on the mean forced expiratory
volume in 1 s (FEV1) trajectory in children with cystic fibrosis in Denmark. Trajectories plotted with other covariates
remained constant for a person born in the 1988–1998 cohort. ISCED: International Standard Classification of Education.
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The impact of novel tests for tuberculosis
depends on the diagnostic cascade
To the Editor:
At least 3 million people with active tuberculosis (TB) are missed by national systems every year. Reaching
these individuals is a critical priority [1]. Novel molecular diagnostics, notably Xpert MTB/RIF (Cepheid
Inc., Sunnyvale, CA, USA) [2, 3], are important tools in this effort. Over 6 million Xpert cartridges have
been procured worldwide since late 2010 [4] but two recent randomised trials in southern Africa [5, 6]
suggest that Xpert, despite high sensitivity, may not significantly reduce morbidity and mortality. It is
therefore useful to demonstrate how TB diagnostics function not in isolation but rather as part of a
‘‘diagnostic cascade.’’
We therefore adapted a transmission model of diagnostic testing among adults with active TB in Southeast
Asia [7]. This model categorises a high-burden population into subpopulations characterised by TB status,
HIV status and access to TB care. Parameter values, available in the original publication, are consistent with
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